Article
Targeting hedgehog signaling reduces self-renewal in embryonal rhabdomyosarcoma
20 Jul 2015
Abstract excerpt
Current treatment regimens for rhabdomyosarcoma (RMS), the most common pediatric soft tissue cancer, rely on conventional chemotherapy, and although they show clinical benefit, there is a significant risk of adverse side effects and secondary tumors later in life. Therefore, identifying and targeting sub-populations with higher tumorigenic potential and self-renewing capacity would offer improved patient...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
